These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 18655195

  • 1. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats.
    Marte A, Pepicelli O, Cavallero A, Raiteri M, Fedele E.
    J Neurosci Res; 2008 Nov 15; 86(15):3338-47. PubMed ID: 18655195
    [Abstract] [Full Text] [Related]

  • 2. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J, Markerink-van Ittersum M, Vles JS.
    J Chem Neuroanat; 2006 Jun 15; 31(4):275-303. PubMed ID: 16621445
    [Abstract] [Full Text] [Related]

  • 3. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.
    Van Staveren WC, Steinbusch HW, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, Beavo JA, De Vente J.
    J Comp Neurol; 2003 Dec 22; 467(4):566-80. PubMed ID: 14624489
    [Abstract] [Full Text] [Related]

  • 4. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.
    Wang M, Urenjak J, Fedele E, Obrenovitch TP.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1619-27. PubMed ID: 15041479
    [Abstract] [Full Text] [Related]

  • 5. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
    Haynes J, Killilea DW, Peterson PD, Thompson WJ.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):752-7. PubMed ID: 8632346
    [Abstract] [Full Text] [Related]

  • 6. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T, Oka M, Noda K, Ukai Y.
    Life Sci; 2004 Aug 27; 75(15):1833-42. PubMed ID: 15302227
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices.
    Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blokland A.
    Behav Brain Res; 2005 Oct 14; 164(1):11-6. PubMed ID: 16076505
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging.
    Domek-Łopacińska K, Strosznajder JB.
    Brain Res; 2008 Jun 24; 1216():68-77. PubMed ID: 18499090
    [Abstract] [Full Text] [Related]

  • 13. ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.
    de Vente J, Markerink-van Ittersum M, Vles JS.
    J Chem Neuroanat; 2006 Jun 24; 31(4):263-74. PubMed ID: 16621444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phosphodiesterases 1 and 2 regulate cellular cGMP level in rabbit submandibular gland cells.
    Michikawa H, Sugiya H, Yoshigaki T, Fujita-Yoshigaki J, Furuyama S.
    Int J Biochem Cell Biol; 2005 Apr 24; 37(4):876-86. PubMed ID: 15694846
    [Abstract] [Full Text] [Related]

  • 16. Various phosphodiesterase activities in different regions of the heart alter the cardiac effects of nitric oxide.
    Demirel-Yilmaz E, Cenik B, Ozcan G, Derici MK.
    J Cardiovasc Pharmacol; 2012 Sep 24; 60(3):283-92. PubMed ID: 22653417
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
    Hepp R, Tricoire L, Hu E, Gervasi N, Paupardin-Tritsch D, Lambolez B, Vincent P.
    J Neurochem; 2007 Sep 24; 102(6):1875-1886. PubMed ID: 17561940
    [Abstract] [Full Text] [Related]

  • 18. Regulation of long-term depression by increases in [guanosine 3',5'-cyclic monophosphate] in the hippocampal CA1 region of freely behaving rats.
    Stricker S, Manahan-Vaughan D.
    Neuroscience; 2009 Jan 12; 158(1):159-66. PubMed ID: 18472342
    [Abstract] [Full Text] [Related]

  • 19. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
    Giorgi M, D'Angelo V, Esposito Z, Nuccetelli V, Sorge R, Martorana A, Stefani A, Bernardi G, Sancesario G.
    Eur J Neurosci; 2008 Sep 12; 28(5):941-50. PubMed ID: 18717735
    [Abstract] [Full Text] [Related]

  • 20. Cyclic nucleotide-dependent phosphodiesterases (PDEI) inhibition by muscarinic antagonists in bovine tracheal smooth muscle.
    Guerra de González L, González de Alfonzo R, Lippo de Bécemberg I, Alfonzo MJ.
    Biochem Pharmacol; 2004 Aug 15; 68(4):651-8. PubMed ID: 15276072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.